Diagnostic BioSystems (DBS), an Immunohistochemistry company with over twenty years of experience in developing Life Science reagents for Anatomic Pathology, announces the commercial launch of their anatomic pathology product offering in the United States. Diagnostic BioSystems’ understanding of high quality Immunohistochemistry products paved the way for the transformation of over 1800 Diagnostic BioSystems products to be manufactured in a cGMP compliant facility with ISO 9001:2000 certification. “Anatomic Pathology demands high quality reagents and DBS is committed to investing resources to maintain the standard needed by pathologists and patients” says Bipin Gupta, CEO of Diagnostic BioSystems. Examples of novel DBS reagents to be launched include:
Specialty Antibodies:
- Rabbit monoclonals
- Angiogenesis
- Apoptosis
- DNA Repair Markers
- Novel Tumor markers
- Cell Cycling
Chromogens:
- Double Staining (PermaBlue, PermaRed, DAB/Plus)
- Triple Staining (DAB/Plus, PermaBlue, PermaRed and PermaGreen)
- Enhanced Staining with (DAB/Plus, AEC/Plus, Intensi/Fire)
Ancillaries:
- Histo/Zyme Antigen Retrieval (gentle enzyme retrieval - 5min RT)
Diagnostic BioSystems is an Immunohistochemistry specialty reagent company dedicated to creating innovative, high quality products for use in challenging applications including monoclonal and polyclonal antibodies and a wide range of detection systems as well as ancillary reagents for high quality immunostaining. Custom Monoclonal and Polyclonal Antibody Production Services include peptide synthesis, in-vitro, as well as in-vivo antibody production, purification and conjugation. Diagnostics BioSystems is based in Pleasanton, CA and is an ISO 9001:2000 and cGMP compliant facility.
For a complete DBS catalog, please visit: http://www.dbiosys.com/catalog2008.pdf
Media contact:
Martha Townsend
Market Ready Rx, Inc.
805-570-8355
Or
Mary Daniel, M.Sc
Director of Sales & Mktg.
Diagnostic BioSystems Inc.
925-202-4797
mary.daniel@dbiosys.com
